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ABSTRACT
FANCJ, a DNA helicase and interacting partner of the
tumor suppressor BRCA1, is crucial for the repair of
DNA interstrand crosslinks (ICL), a highly toxic le-
sion that leads to chromosomal instability and per-
turbs normal transcription. In diploid cells, FANCJ
is believed to operate in homologous recombination
(HR) repair of DNA double-strand breaks (DSB); how-
ever, its precise role and molecular mechanism is
poorly understood. Moreover, compensatory mech-
anisms of ICL resistance when FANCJ is deficient
have not been explored. In this work, we conducted
a siRNA screen to identify genes of the DNA dam-
age response/DNA repair regime that when acutely
depleted sensitize FANCJ CRISPR knockout cells to
a low concentration of the DNA cross-linking agent
mitomycin C (MMC). One of the top hits from the
screen was RAP80, a protein that recruits repair ma-
chinery to broken DNA ends and regulates DNA end-
processing. Concomitant loss of FANCJ and RAP80
not only accentuates DNA damage levels in human
cells but also adversely affects the cell cycle check-
point, resulting in profound chromosomal instabil-
ity. Genetic complementation experiments demon-
strated that both FANCJ’s catalytic activity and in-
teraction with BRCA1 are important for ICL resis-
tance when RAP80 is deficient. The elevated RPA
and RAD51 foci in cells co-deficient of FANCJ and
RAP80 exposed to MMC are attributed to single-
stranded DNA created by Mre11 and CtIP nucleases.
Altogether, our cell-based findings together with bio-
chemical studies suggest a critical function of FANCJ
to suppress incompletely processed and toxic joint
DNA molecules during repair of ICL-induced DNA
damage.
INTRODUCTION
Interstrand cross-links (ICLs) are a formidable type of
DNA damage that interfere with cellular DNA replication
and transcription (1). In replicating cells, persistent ICLs
represent a lethal form of chromosomal damage because
they result in highly recombinogenic DNA double-strand
breaks (DSBs), causing a loss of genetic information. His-
torically, ICLs were known to arise from exposure to cer-
tain clastogenic compounds (e.g. nitrogen mustard) used
in chemical warfare (2). Ironically, cancer clinics began to
use ICL-inducing agents as chemotherapy drugs to treat
leukemia and various solid tumors (3). Rapidly dividing
cancer cells are hypersensitive to the DNA damaging effects
of cisplatin, psoralen, mitomycin C (MMC) and other DNA
cross-linking drugs; however, the cytotoxicity of such com-
pounds for normal (noncancerous) cells has posed a sig-
nificant drawback for their efficacy in combating cancer. A
source of endogenous ICLs was discovered to be formalde-
hyde and aldehyde derivatives, which arise from cellular
metabolic processes including lipid peroxidation and oxida-
tive demethylation reactions (4,5). Experimental evidence
now also points to alcohol consumption contributing to
acetaldehyde accumulation, ultimately leading to macro-
molecule damage, including genomic DNA ICLs (6).
A primary pathway for the repair of DNA ICLs is or-
chestrated by a set of >20 proteins in which the correspond-
*To whom correspondence should be addressed. Tel: +1 410 558 8578; Email: broshr@grc.nia.nih.gov
Published by Oxford University Press on behalf of Nucleic Acids Research 2020.









edical School user on 04 N
ovem
ber 2020
9162 Nucleic Acids Research, 2020, Vol. 48, No. 16
ing mutations are linked to a chromosomal instability dis-
order known as Fanconi Anemia (FA) (7). The FA pathway
of ICL repair is a complex multi-step process with several
functional levels including DNA ICL detection, pathway
activation, unhooking of the ICL, translesion DNA syn-
thesis past the ICL remnant, and recombinational repair
to restore genomic integrity (8). In the absence of a func-
tional FA pathway, cells attempt to cope with ICL-induced
DNA damage, typically DSBs, by eliciting homologous re-
combination (HR) or nonhomologous end-joining (NHEJ)
which differ significantly in their fidelity of repair (9). The
most poorly understood class of FA proteins are those ded-
icated to HR repair of the DSBs arising from downstream
processing of the ICL-induced DNA damage. Among these
proteins is the BRCA1-interacting FANCJ DNA helicase in
which mono-allelic mutations are associated with cancers of
the breast (10) and ovary (11). Although purified recombi-
nant FANCJ helicase protein is known to unwind duplex
(12,13) and G-quadruplex (14–16) DNA substrates in vitro,
as well as remove the major strand exchange protein Rad51
from DNA in an ATP-dependent manner (17), its cellular
role(s) in HR repair and maintenance of genomic stability
is enigmatic. Cells deficient in FANCJ display a HR defect
(18) and are hypersensitive to treatments that cause DNA
ICLs or DSBs (for review, see (19)), as well as drugs that
cause replication stress (14,20,21), but FANCJ’s precise sub-
strates and mechanism(s) of action in vivo are not well char-
acterized.
To better understand the cellular response to ICL-
induced DNA damage, we screened DNA damage
response/DNA repair gene targets that when depleted
sensitize human FANCJ CRISPR knockout (KO) cells
to a very low dose of an ICL-inducing agent. Among the
leading hits is RAP80, a ubiquitin-binding protein that
is believed to recruit BRCA1 and other proteins to DSBs
and modulate DNA end-processing (22). The results from
cell-based assays, together with the biochemical discovery
of a novel DNA branch-migration activity catalyzed by
FANCJ, suggest a model in which the loss of FANCJ and
RAP80 cause severe defects by impairing maturation of
HR repair intermediates incurred by ICL-induced DNA
damage. Meanwhile, a compromised cell cycle checkpoint
in these cells resulted in their progression into mitosis
with unrepaired DNA damage. The potential clinical
importance of our findings in terms of chromosomal
instability imposed by dual loss of FANCJ and RAP80,
and the efficacy of DNA cross-linking agents used in cancer
therapy, is discussed.
MATERIALS AND METHODS
Cell culture, knockdown and DNA transfection
U2OS FANCJ KO and HeLa FANCJ KO cells were gen-
erated as previously described (20). U2OS RAP80 KO
cells and MERIT40 KO cells were generated as previ-
ously described (23). HEK293 Abraxas KO cells were gen-
erated as previously described (24). DR-GFP U2OS (25)
and EJ5 U2OS (26) were gifts from Dr Xiaofan Wang
(Duke University, USA) and Dr Jeremy Stark (City of
Hope, USA), respectively. All cells were cultured in DMEM
medium with 10% fetal bovine serum (Sigma-Aldrich) and
1× penicillin/streptomycin (Gibco) in an atmosphere of 5%
CO2 at 37◦C.
For siRNA-mediated knockdown, siRNA was diluted
with Opti-MEM medium (Gibco) and then mixed with IN-
TERFERin (Polyplus transfection) according to the man-
ufacturer’s instructions. Cells were transfected with a fi-
nal concentration of 30 nM siRNA. For stable expression
of exogenous FANCJ, FANCJ KO cells were transfected
with plasmids encoding GFP, GFP-FANCJ-WT and GFP-
FANCJ-H396D by using Lipofectamine 2000 as per man-
ufacturer’s instruction. After 30 days of selection in G418
(500 g/ml), cells expressing high levels of GFP were sorted
by flow-cytometry.
RNAi screen
The primary screen was performed in triplicate in 96-
well plates as described previously (27,28), utilizing a
Dharmacon-DNA damage response siRNA library consist-
ing of a pool of four siRNAs per gene and two non-targeting
control siRNAs. Two-thousand WT or FANCJ CRISPR
KO cells were seeded in 96-well plates and reverse trans-
fected with the library of 25 nM gene-specific pool siRNAs
using INTERFERin transfection reagent (Polyplus). Each
96-well plate contained 80 gene-specific pool siRNAs and
two control siRNAs. Twenty-four hr after transfection, me-
dia was removed and cells were incubated in fresh media
with or without 6.25 nM MMC at 37◦C for 72 h. Cell via-
bility was measured by the WST-1 cell proliferation assay,
and percentage viability of WT or FANCJ KO cells trans-
fected with the siRNA pool against the indicated gene was
calculated by normalizing the absorbance values of the cells
transfected with the gene-specific siRNA to that of the con-
trol siRNA. The screening was done in triplicate, and mean
percent viability relative to control siRNA is plotted for
each individual siRNA with standard deviations indicated
by error bars. A minimum loss of 30% cell viability in the
FANCJ KO cells (compared to the isogenic WT cells) was
set as a threshold cutoff to select gene-targeted siRNA pools
that sensitize U2OS cells as a function of FANCJ status.
In addition, we used a threshold cutoff minimum of 55%
reduction in viability of the FANCJ KO cells transfected
with the target RNAi pool compared to the same cells trans-
fected with control RNAi.
Western blot analysis
Cells were lysed in 1× SDS sample buffer (Millipore).
Lysates were sonicated for 15 s and heated at 100◦C for 5
min. Proteins were separated on 6–12% SDS-PAGE gels
and transferred to PVDF membranes (Millipore). Mem-
branes were blocked with 5% non-fat milk or BSA, and
then incubated with primary antibodies overnight at 4◦C.
After washing with 1× PBS with 0.1% Tween-20, the
HRP-conjugated secondary antibodies were then added
to PVDF membrane. Membranes were developed with
Pierce ECL or Femto Western Blotting Substrate (Thermo-
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Colony formation assay
Cells were transfected with 30 nM of indicated siRNAs.
After 24 h cells were re-transfected. Forty-eight hr after the
first transfection, 500–1000 cells according to plating effi-
ciency were seeded in six-well plates with media containing
the specified MMC or cisplatin concentration. Cells were
incubated for 6 days in MMC or cisplatin after which media
was changed. The cells were allowed to recover for 14 days
after seeding, and then fixed with 100% methanol for 20
min and stained with 0.5% crystal violet in 25% methanol
at room temperature for 20 min. The dishes were gently
washed with water and dried in the air. Colonies were
counted and percent survival is expressed as the number of
colonies in the MMC-treated or cisplatin-treated condition
at the indicated dose of drug compared to the untreated
condition. The results are presented as the mean ± standard
error of mean (s.e.m.) from three independent
experiments.
Annexin staining
Cells were transfected with 30 nM of indicated siRNAs. Af-
ter 24 h cells were re-transfected. Forty-eight hr after the
first transfection, cells were treated with 3 M MMC or ve-
hicle control for 1 h and allowed to recover in fresh media.
After 72 h treatment, apoptosis was measured with Annexin
V–FITC/PI staining kit (Abcam) by flow cytometry analy-
sis. The results are presented as the mean ± s.e.m. from three
independent experiments.
Immunofluorescence assay
Cells were cultured onto four-well Nunc chamber slides.
To detect RPA, Rad51, CtIP and BRCA1 foci, we per-
formed pre-extraction for 5 min on ice in CSK buffer
followed by fixation with 4% PFA/PBS for 10 min, per-
meabilization in 0.5% Triton X-100/PBS for 15 min and
blocking in 10% FBS/PBS for 1 h. Cells were incubated
overnight with specific primary antibody: mouse anti-RPA
(EMD Millipore); rabbit anti-Rad51 (Abcam); mouse anti-
BRCA1 (Santa Cruz); rabbit anti-CtIP (Abcam) at 4◦C
in 1% BSA/PBS, followed by species-specific fluorescein-
conjugated secondary antibodies (Alexa Fluor 594 Anti-
Rabbit or Alexa Fluor 488 Anti-Mouse), and counter-
stained with DAPI. Slides were analyzed with Zeiss Axio
Observer.Z1 Fluorescence Microscope. For each time point,
at least 75 nuclei were scored at 63× magnification, and the
results are presented as the mean ± s.e.m. from three inde-
pendent experiments.
BrdU assay
Cells grown in the presence of 10 M BrdU (Sigma) and 3
M MMC for 16 h and immunofluorescence stained with
mouse anti-BrdU antibody (Sigma) under non-denaturing
conditions to detect BrdU incorporated into ssDNA as de-
scribed previously (29). For each time point, at least 75
nuclei were scored at 63× magnification to determine av-
erage number of BrdU foci per nucleus. The results are
presented as the mean ± s.e.m. from three independent
experiments.
Laser localized ICLs
A diamond pen was used to score a cross in the center
of the growth surface of a 35 mm glass bottom culture
dish prior to plating cells. This facilitated identification
of targeted cells during imaging of immuno-stained cells.
Prior to an experiment the cells were incubated with ei-
ther 6 M trimethyl psoralen (TMP) for 20 min prior to
laser treatment. The plates were placed in an environmental
chamber, maintained at 37◦C, 5% CO2 and 80% humidity,
mounted on a Nikon Eclipse TE2000 confocal microscope.
Cells were visualized with a Plan Fluor ×60/1.25 numer-
ical aperture oil objective. The microscope was equipped
with an SRS NL100 nitrogen laser-pumped dye laser (Pho-
tonics Instruments, St. Charles, IL, USA). To photoacti-
vate the psoralens, defined regions of interest (ROI, 4 ×
20 pixels, 0.16 m/pixel) in individual nuclei, in the vicin-
ity of the etched cross, were exposed to the laser firing 3-
ns pulses at 365 nm with a repetition rate of 10 Hz. The
power measured at the back aperture of the ×60 objective
was 0.7 nW. The laser was controlled by Volocity-5 software
(Improvision; PerkinElmer Life Sciences). The beam was
oriented by galvanometer-driven displacers and fired ran-
domly throughout the region until the entire region was ex-
posed. The diffraction-limited spot size was ∼300 nm. Two
firing cycles were applied to each region.
ssDNA assay
Cells were labeled with 20 M CldU for 48 h prior to in-
troducing laser localized ICLs. During a 2.5 h incubation
period post targeting, the cells were exposed to 100 M cy-
tosine arabinoside (ara-C) to prevent repair synthesis. Fix-
ing procedure for the assay was as follows: one 3 min treat-
ment on ice with CSK1 buffer (10 mM Pipes, 100 mM NaCl,
300 mM sucrose, 3 mM MgCl2, 0.05% Triton X-100) and
another 3 min treatment on ice with CSK2 buffer (10 mM
Tris pH 7.4, 10 mM NaCl, 1% Tween. 0.5% deoxycholate
and 3 mM MgCl2). Following detergent treatments, cells
were fixed in 2% formaldehyde mixed with 2% sucrose for 10
min at room temperature, and washed with PBS-T (1× PBS,
0.05% Tween-20). To visualize CldU at laser stripe, cells
were exposed to appropriate primary and secondary an-
tibodies without acid treatment. To control for genomic
DNA labeling, a second set of plates was treated with 2.5
M HCl for 1 h, followed by 200 mM Tris–HCl pH 8.0, and
a wash with PBS, prior to blocking (see below).
Fixed cells were permeabilized with 0.5% Triton X-100,
1% bovine serum albumin, 100 mM glycine, and 0.2 mg/ml
EDTA in PBS at 4◦C for 10 min, digested with RNase
A in PBS-EDTA (5 mM) solution for 30 min at 37◦C,
blocked in 10% goat serum and 5% BSA in PBS and 0.01%
sodium azide for 1 h at room temperature, and then incu-
bated with appropriate primary antibody diluted in block-
ing solution for 1 h at 37◦C in a humid chamber [mouse
anti- -H2AX 1:1000 (EMD Millipore, #05–636), Rat anti-
BrdU (1:200) Abcam #ab6326]. −H2AX stained the tar-
geted ROI, BrdU labeled the CldU labeled ssDNA. Af-
ter three 10 min washes in PBS-T, cells were incubated
with fluorescence-tagged secondary antibodies [AF488 goat
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1:1000, Invitrogen] for 1 h at 37◦C, washed three times for
10 min in PBS-T, and mounted in Prolong + DAPI.
HR and NHEJ assays
The HR repair and NHEJ assays were performed in DR-
GFP U2OS cells and EJ5 U2OS cells, respectively. Cells
were transfected with 30 nM of indicated siRNAs. After
24 h cells were re-transfected. Forty-eight hours after the
first transfection, cells were transfected with the plasmids
expressing I-SceI endonuclease and DsRed. Four days after
the first transfection, the cells were harvested and analyzed
by flow cytometry for the expression of GFP and DsRed.
Flow cytometry data were collected from 10 000 to 50 000
cells. The results are presented as mean ± s.e.m. from three
independent experiments.
Detection of chromosomal aberrations
Cells were incubated with 100 ng/ml colcemid at 37◦C for 3
h. Cells for metaphase preparation were collected according
to standard procedure as previously described (30). In brief,
the cellular pellet was resuspended in prewarmed 0.075 M
KCl solution and incubated at 37◦C for 20 min followed by
addition of fixative solution (3:1 methanol/acetic acid). Cell
suspension was dropped onto cold slides to make chromo-
some preparations. The slides were air dried overnight and
stored at −20◦C until analysis. Chromosomal aberrations
were examined in Giemsa-stained metaphases under a Zeiss
Axio Observer.Z1 microscope. At least 50 chromosomes
were examined, and chromosomal abnormalities scored at
100× magnification.
DNA branch-migration assay
Oligonucleotides used for DNA substrates are listed in Ta-
ble 1. To prepare substrates for 3′ → 5′ or 5′ → 3′ three-
stranded branch migration, 25 pmol of DNA oligos 169 (3′
→ 5′) or 193 (5′ → 3′) were labeled with 30 Ci  32P-ATP
(Perkin Elmer) and T4 Polynucleotide kinase (New England
Biolabs) and unincorporated ATP removed. The radiola-
beled 169 or 193 oligos were annealed to 25 pmol of 71 or
117 in TE pH 8.0 by heating at 95◦C followed by slow cool-
ing to RT. The 169/71 and 193/117 duplexes (0.5 nM) were
mixed with DNA oligos 201 or 379 (1 nM), respectively in
branch migration buffer containing 25 mm Tris acetate, pH
7.5, 2 mM ATP, 5 mm magnesium acetate, 2 mM DTT, 100
g/ml BSA, 15 mM phosphocreatine, and creatine phos-
phokinase (30 units/ml) for 15 min at 37◦C. To prepare sub-
strate for examining DNA helicase activity the 169*/71 du-
plex was mixed with ssDNA oligonucleotide 248HEL as de-
scribed above. Reactions were initiated by adding FANCJ
(1.25 nM) for 30 min or 0–60 min for kinetics experiments.
Reactions were stopped by adding 1.5% SDS and proteinase
K (800 g/ml) for 15 min at 37◦C, followed by 0.1 volumes
of loading dye (70% glycerol, 0.1% bromophenol blue) prior
to loading the on 8% polyacrylamide 1× TBE gels. Gels
were run at 135 V for 1.5 h. Gels were exposed to a phospho-
rscreen, visualized with a Typhoon FLA 9500 (GE Health-
care), and quantified using ImageQuant (GE Healthcare).
RESULTS
RNAi screen of isogenic FANCJ knock-out and wild-type
cells
We conducted a siRNA screen to identify genes of the DNA
damage response/DNA repair regime that when acutely
depleted sensitize FANCJ KO cells to the DNA damag-
ing effects caused by a relatively low concentration of the
DNA cross-linking agent MMC. The FANCJ KO cells pre-
viously described (20) were confirmed to have complete loss
of FANCJ by Western blot (Supplementary Figure S1A).
A very low dose of MMC (6.25 nM) was chosen such that
by itself the drug exerted only a minimal effect on viabil-
ity of the FANCJ KO cells when compared to the isogenic
WT cells (Supplementary Figure S1B). We used a custom
siRNA library that contains 240 known DNA damage re-
sponse and repair genes with a pool of four individual siR-
NAs per gene in separate wells of 96-well plates. The WT
and FANCJ KO cells were individually transfected with the
indicated pool siRNA library gene targets. Twenty-four hr
later the media was changed, and cells were either left un-
treated or exposed to 6.25 nM MMC for 72 h. Cell viability
was subsequently measured by the WST-1 cell proliferation
assay, and percentage viability of the WT or FANCJ KO
cells transfected with each gene-targeted siRNA pool was
calculated by normalizing the absorbance values of the in-
dividual gene-targeted siRNAs to that of the control (non-
specific) siRNA. The screen was completed in triplicate, and
the mean percent viability is plotted for each siRNA in the
absence or presence of MMC (Supplementary Figures S2
and S3).
Reduced colony survival of cells deficient in both FANCJ and
RAP80 after mitomycin exposure
UIMC1/RAP80 (hereafter referred to as RAP80) was one
of the top hits in the RNAi screen, displaying under con-
ditions of 6.25 nM MMC exposure a 45% reduced prolif-
eration of FANCJ KO cells compared to WT cells (Figure
1A). The reduced proliferation caused by the co-deficiency
of FANCJ and RAP80 in MMC-treated cells led us to test
for cell survival by a clonogenic assay. The clonogenic as-
say is devised to determine reproductive cell death to as-
sess drug sensitivity (31); consequently, it provides a sensi-
tive measurement of cell division not assessed by the RNAi
screen’s metabolic activity assay. Initially, the isogenic pair
of FANCJ KO or WT cells were tested for sensitivity to
increasing MMC concentrations to determine an optimal
dose (Supplementary Figure S4), followed by clonogenic
assays of the isogenic FANCJ KO and WT cells trans-
fected with RAP80 RNAi or control siRNA (Figure 1).
Cells transfected with RAP80 siRNA displayed little to no
RAP80 as detected by Western blot (Figure 1B). As shown
in Figure 1C and D, FANCJ KO cells depleted of RAP80
showed significantly reduced survival at an MMC concen-
tration as low as 0.2 nM compared to FANCJ KO cells
transfected with control siRNA. At 0.38 nM MMC, the
RAP80-depleted FANCJ KO cells displayed 35% survival
compared to 70% survival of the control siRNA transfected
FANCJ KO cells. WT cells depleted of RAP80 only showed









edical School user on 04 N
ovem
ber 2020
Nucleic Acids Research, 2020, Vol. 48, No. 16 9165
Table 1. Oligonucleotides used to prepare DNA substrates for FANCJ biochemical assays















Figure 1. Loss of RAP80 sensitizes FANCJ KO cells to a low dose of Mitomycin C. Panel (A), RNAi screening performed as described in Materials and
Methods demonstrated that UIMC1 (RAP80) was one of the ten positive hits of the 240 DNA damage response genes that in RNAi-depleted FANCJ
KO cells sensitized them to 6.25 nM MMC as measured by a cell viability assay. Panel (B), Western blot showing RNAi-mediated RAP80 depletion in the
isogenic FANCJ KO and WT cell lines. Panel (C), WT or FANCJ KO cells were transfected with 30 nM control siRNA or RAP80 pool siRNA. After 24
h cells were re-transfected with 30 nM control siRNA or RAP80 pool siRNA, and 500–1000 cells were seeded in six-well plates with media containing the
specified MMC concentration. Cells were incubated for 6 days after which media was changed. Colonies were detected 14 days after the initial seeding
using crystal violet staining. Panel (D), Quantification of colony formation from three independent experiments.
dicating that the combined deficiency of both RAP80 and
FANCJ resulted in a greater decrease in survival compared
to either FANCJ or RAP80 deficiency alone. Heightened
sensitivity of FANCJ/RAP80 co-deficient cells was also ob-
served at MMC doses of 0.76 and 1.52 nM (Figure 1D).
To address the specificity of the effects caused by the pool
RNAi depletion of RAP80, we tested individual siRNAs
against RAP80 for their sensitization of FANCJ KO cells
to MMC. As shown by western blot, RAP80 siRNA#1 was
very effective in depleting RAP80 (Supplementary Figure
S5A). Moreover, FANCJ KO cells depleted of RAP80 by
siRNA #1 behaved very similarly to those cells depleted of
RAP80 by the pool siRNA in terms of their sensitization
to MMC (Supplementary Figure S5B). At an MMC dose
of 0.37 nM, the percentage survival of FANCJ KO cells
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57% compared to a combined reduction of 35% attributed
to FANCJ KO (29%) and RAP80 depletion (6%). These
results suggest that a combined deficiency of FANCJ and
RAP80 together exerts a more severe effect on MMC sur-
vival compared to the additive effects of FANCJ deficiency
and RAP80 deficiency.
Because ALT cells (such as the U2OS cell line used in the
RNAi screen) are known to have aberrant HR pathways
and are partially deficient due to lack of ATRX gene ex-
pression (32), we tested two non-ALT cell lines (HeLa and
HEK293 (see below)) to evaluate the broader applicabil-
ity of the apparent FANCJ-RAP80 genetic interaction. As
shown in Supplementary Figure S5C, at an MMC concen-
tration of 0.38 nM RAP80-depleted FANCJ KO HeLa cells
displayed 48% survival compared to 75% survival for the
FANCJ KO cells transfected with control siRNA or 85%
survival for WT cells depleted of RAP80. A hypersensitivity
of HeLa cells co-deficient in FANCJ and RAP80 to other
MMC doses was also observed.
To extend the finding that cells deficient in both FANCJ
and RAP80 are hypersensitive to ICL-induced DNA dam-
age, we tested the effect of the DNA cross-linking agent cis-
platin (Supplementary Figure S5D). As expected, WT cells
transfected with a control siRNA displayed only modest
sensitivity to a low cisplatin dose range of 7.5–60 nM as de-
termined by colony survival assays. RAP80-depleted cells
were also resistant to these concentrations of cisplatin, con-
sistent with what was observed for the DNA cross-linking
agent MMC (Figure 1 and Supplementary Figure S5B).
FANCJ KO cells showed sensitivity to cisplatin in a dose-
dependent manner (Supplementary Figure S5D). However,
FANCJ KO cells depleted of RAP80 displayed a signifi-
cantly greater sensitivity to cisplatin at all concentrations
tested, consistent with the results from the MMC experi-
ments.
We next performed annexin V-FITC and propidium io-
dide (PI) staining to determine the percentage of apoptotic
and necrotic cells after an acute 1 h exposure to 3 M
MMC. FANCJ KO or WT cells depleted of RAP80 dis-
played similar percentages of death (25% and 23%, respec-
tively) when examined 72 h after MMC exposure compared
to only ∼6% apoptosis/necrosis for WT cells transfected
with control siRNA (Supplementary Figure S6). In con-
trast, 46% of the RAP80-depleted FANCJ KO cells exposed
to MMC were apoptotic or necrotic. These findings demon-
strate that acute exposure of FANCJ- and RAP80-deficient
cells to MMC caused a significantly greater level of death
compared to cells deficient of FANCJ or RAP80.
To confirm the findings from the colony survival experi-
ments with FANCJ KO cells (Figure 1), we performed re-
ciprocal experiments with RAP80 KO cells (Figure 2B).
RAP80 KO cells depleted of FANCJ displayed greater
MMC sensitivity than the combined MMC sensitivity of
FANCJ-depleted WT cells and RAP80 KO cells treated
with control siRNA. Taken together with the results shown
in Figure 1, we conclude that the combined loss of both
FANCJ and RAP80 renders cells more sensitive to MMC
than the additive effects of FANCJ deficiency and RAP80
deficiency.
The apparent synergism between FANCJ and RAP80
due to loss of one by CRISPR KO and the other by RNAi
depletion led us to attempt to CRISPR double KO of both
FANCJ and RAP80. After several attempts, we were unsuc-
cessful in creating FANCJ/RAP80 double KO’s with U2OS
cells, indicating that the combined complete loss of both
FANCJ and RAP80 is lethal. While we were able to iso-
late a limited number of small surviving colonies that we
believe to be knocked out for both FANCJ and RAP80 in
HeLa, the cells were extremely slow growing (again consis-
tent with a strong synthetic sickness), making it technically
difficult to perform any reliable experiments.
Merit40 deficiency exacerbates MMC sensitivity of FANCJ-
depleted cells
Merit40 resides in a RAP80 protein complex that facilitates
the targeting of BRCA1 to DNA lesions (33–35). To de-
termine if Merit40 deficiency behaves in a manner similar
to RAP80 in terms of its genetic interaction with FANCJ,
we performed MMC survival assays with isogenic Merit40
KO or WT cells transfected with control siRNA or FANCJ
siRNA. We observed that the reduction in colony forma-
tion for Merit40 KO cells was less than that observed for
WT cells depleted of FANCJ (Figure 2D). Merit40 KO cells
depleted of FANCJ showed even further reduced survival
throughout the MMC titration range (0.075–1.5 nM) com-
pared to the additive loss in cell survival upon MMC expo-
sure for Merit40 KO cells transfected with control siRNA
and WT cells transfected with FANCJ siRNA (Figure 2D).
For example, Merit40 KO cells displayed a 20% reduction in
survival at an MMC dose of 0.75 nM, and FANCJ-depleted
WT cells showed a 32% reduction in survival, whereas the
combined loss of the two resulted in an 81% reduced colony
survival. These results suggest that like RAP80, Merit40
deficiency combined with FANCJ deficiency exacerbates
MMC sensitivity as measured by colony survival assays.
FANCJ catalytic activity is required to suppress heightened
MMC sensitivity in a RAP80-deficient background
We next wanted to determine if the synergistic effect of
RAP80 and FANCJ co-deficiency on MMC sensitivity was
dependent on FANCJ catalytic activity. To address this, we
asked whether expression of a clinically relevant FANCJ
ATPase domain mutant designated FANCJ-H396D, which
we previously determined to be severely compromised in
its ATP hydrolysis and completely dead as a helicase (36),
in a FANCJ KO background depleted of RAP80 could
rescue the MMC sensitivity. FANCJ KO cells were sta-
bly transfected with a GFP expressing empty vector, GFP-
WT-FANCJ, or GFP-FANCJ-H396D. Western blot analy-
sis confirmed that the expression level of FANCJ-H396D
mutant was nearly the same as that of WT-FANCJ nor-
malized to the loading control actin (Supplementary Fig-
ure S7A). FANCJ KO cells stably expressing GFP-WT-
FANCJ, GFP-FANCJ-H396D or empty vector transfected
with RAP80 siRNA displayed little detectable RAP80 as
assessed by Western blot (Supplementary Figure S7B)
At an MMC concentration of 0.18 nM, the RAP80-
depleted FANCJ KO cell line expressing FANCJ-H396D
showed a 57% reduction in survival, comparable to what
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Figure 2. RAP80 KO cells or Merit40 KO cells depleted of FANCJ are hypersensitive to MMC. Panels (A) and (C), western blot showing RNAi-mediated
FANCJ depletion in the isogenic RAP80 KO or Merit40 KO and WT cell lines. Panels (B) and (D), WT and RAP80 KO or Merit40 KO cells were transfected
with 30 nM control siRNA or FANCJ siRNA. After 24 h cells were re-transfected with 30 nM control siRNA or FANCJ siRNA, and 500–1000 cells were
seeded in 6-well plates with media containing the specified MMC concentration. Cells were incubated for 6 days after which media was changed. Colonies
were detected 14 days after the initial seeding using crystal violet staining. Quantification of colony formation is from three independent experiments.
fected with a GFP construct (60% reduction) (Supplemen-
tary Figure S7C). This reduction was significantly greater
than the 28% reduction in FANCJ KO cells transfected
with control siRNA. WT cells depleted of RAP80 only
showed 6% reduction in survival. Therefore, the additive
effect of RAP80 depletion and FANCJ KO was ∼1.7-fold
less than that of the combined deficiency of FANCJ and
RAP80, confirming their synergistic interaction. Moreover,
expression of the catalytically defective FANCJ-H396D in
the RAP80-depleted FANCJ KO cells did not alter this ef-
fect, suggesting that FANCJ’s intact ATPase/helicase ac-
tivity is required for MMC resistance even when RAP80 is
depleted.
Concomitant deficiency of FANCJ and RAP80 causes ICL-
induced ssDNA accumulation and elevated RPA and RAD51
foci in MMC-treated cells
Several reports suggest that RAP80 recruits and sequesters
BRCA1 to the HR repressive BRCA1-A complex (37–39).
RAP80 represses HR in response to DSBs by blocking
DNA end-resection (40,41). BRCA1, which resides with
FANCJ in a distinct complex from that of RAP80 (39),
is also required to promote HR via its interaction with
FANCJ (18). We hypothesized that depletion of RAP80
would result in accumulation of single-stranded (ss) DNA
due to excessive end-resection and loss of FANCJ would
further inhibit processing of the excessively resected DNA.
Therefore, we asked if there was an increased amount of
single-stranded DNA persisting at sites of laser-activated
Pso-ICL 150 min post laser targeting. As shown in Figure
3A and B, the FANCJ KO cells depleted of RAP80 dis-
played ∼2.3-fold greater staining for CldU-marked ssDNA
detected in  -H2AX stripes compared to the isogenic WT
cells transfected with control siRNA. These results suggest
the accumulation of single-stranded DNA over time in cells
co-deficient of FANCJ and RAP80 that are subjected to
ICL-induced damage.
In the experiments with MMC, heightened nuclear Repli-
cation Protein A (RPA) and RAD51 foci may be attributed
to the over-abundant DNA end-resection and lack of sub-
sequent maturation of the RPA-coated and RAD51-coated
ssDNA molecules. Indeed, our experimental data suggest
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Figure 3. Dual loss of FANCJ and RAP80 results in ssDNA accumulation at ICL-induced DNA damage, and elevated RPA and RAD51 foci in MMC-
treated cells. Panels (A) and (B), Pso-ICL CldU ssDNA accumulation. WT or FANCJ KO cells were transfected with 30 nM control siRNA or RAP80
siRNA#1. After 24 h cells were re-transfected with 30 nM control siRNA or RAP80 siRNA#1. Cells were kept in 20 M CldU for 48 hr. Forty-eight
hr after the first transfection, cells were incubated with psoralen followed by laser treatment (1%) to induce Pso-ICLs. Cells were fixed and stained with
anti- -H2AX and anti-CldU antibody. Panel (A), representative images of −H2AX and CldU stripes. Panel (B), The mean intensity of CldU localized
to ICL stripes were quantified in single cells at 150 min after laser treatment. Panels (C–F), Number of RPA and RAD51 foci per cell are elevated in
the non-treated and MMC-treated cells doubly deficient in RAP80 and FANCJ. WT or FANCJ KO cells were transfected with 30 nM control siRNA or
RAP80 siRNA#1. After 24 hr cells were re-transfected with 30 nM control siRNA or RAP80 siRNA#1. Forty-eight hours after the first transfection,
cells were either left untreated or were treated with 3 M MMC for 1 h and allowed to recover in fresh media. Sixteen hours later, RPA (Panels C, D) and
Rad51 foci (Panels E, F) were determined after removing the soluble proteins and fixing chromatin bound proteins. Shown are representative images of
the MMC-treated cells and quantitative analyses of both the untreated and MMC-treated cells. Over 150 cells were examined, and the results are mean ±
standard error of mean (s.e.m.) from three biological repeats, with P-values determined by Student’s t-tests.
M MMC for 1 h followed by a 16 h incubation showed
a 1.3-fold increase in the average number of RPA foci per
cell compared to WT cells, whereas depletion of RAP80
in WT cells elevated the number RPA foci per cell by 2.1-
fold (Figure 3C and D). However, loss of both FANCJ and
RAP80 resulted in a 2.9-fold increase in number of RPA
foci per cell. For RAD51 staining, deficiency of FANCJ or
RAP80 in the MMC-treated cells resulted in 1.8-fold and
2.5-fold increases in number of cells with Rad51 foci per cell,
whereas deficiency of both FANCJ and RAP80 resulted in
a 3.2-fold increase in RAD51 staining (Figure 3E-F). In the
absence of MMC treatment, depletion of FANCJ and/or
RAP80 also resulted in significantly higher number of RPA
and Rad51 foci per cell (Figure 3D, F).
We performed a time-course experiment to examine the
effect of FANCJ and/or RAP80 depletion on the appear-
ance and disappearance of RPA and Rad51 foci to de-
termine their temporal dynamics of foci formation during
ICL repair. FANCJ KO cells displayed similar abundance
of RPA and Rad51 foci in response to MMC treatment at
both the 6 and 12 h time-points compared to control siRNA
transfected cells (Supplementary Figure S8A and B). How-
ever, there was a 2-fold greater number of cells with >10
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at the 24 h time-point post MMC exposure (Supplemen-
tary Figure S8A). A significantly 4-fold greater number of
FANCJ-KO cells with 10 or more RPA foci persisted at 36 h
compared to the WT cells which showed a decline compared
to the 24-h timepoint. RAP80-depleted FANCJ KO or WT
cells showed comparably elevated percentage with greater
than 10 RPA foci at the 6 or 12 h time-point compared to
cells not depleted of RAP80. Notably, FANCJ KO cells de-
pleted of RAP80 displayed nearly 70% with >10 RPA foci
at 24 h post MMC exposure and the elevated level persisted
at 36 h, significantly more than the WT cells depleted of
RAP80. Based on these results, we conclude that through-
out the time course of recovery from 6–36 h, RPA foci per-
sisted to the greatest extent in cells deficient of both FANCJ
and RAP80 (Supplementary Figure S8A).
We next examined the percentage of cells in the
FANCJ/RAP80 series that displayed >10 Rad51 foci (Sup-
plementary Figure S8B). Here, we observed a similar pat-
tern to that of cells with abundant RPA foci. Rad51 foci
were enriched in RAP80-depleted FANCJ KO or WT cells
throughout the time-course; however, notably the percent-
age of RAP80-depleted FANCJ KO cells with >10 Rad51
foci persisted at the 24 and 36 h time-points post MMC ex-
posure, reaching a very high level of ∼70% (Supplementary
Figure S8B). We conclude from these data that like RPA
foci, Rad51 foci persisted in the most abundant manner in
those cells deficient in both FANCJ and RAP80. Taken to-
gether, these results suggest that ICL repair intermediates
bound by RPA and Rad51 persist in cells co-deficient in
FANCJ and RAP80.
To validate that the increased RPA foci formation in cells
exposed to MMC is attributed to elevated ssDNA, we ex-
amined for BrdU foci in cells prelabeled with the nucleotide
analogue with an antibody that specifically recognizes BrdU
in the single-stranded state, following a published proto-
col (29) (Supplementary Figure S9). We found that a de-
ficiency of FANCJ or RAP80 in the MMC-treated cells re-
sulted in 1.4-fold and 2.1-fold increases in the number of
BrdU foci per cell, respectively. Deficiency of both FANCJ
and RAP80 resulted in a 2.7-fold increase in the number of
BrdU foci per cell, as measured by these parameters. These
results are consistent with the increase in RPA and RAD51
foci which we observed in these cells after treatment with
MMC.
We next performed a reciprocal set of experiments and
assessed the number of RPA and RAD51 foci per cell
in MMC-treated RAP80 KO cells that were depleted of
FANCJ (Supplementary Figure S10). As expected, loss of
RAP80 alone resulted in a significant (1.8-fold) increase
in the average number of RPA foci per cell (Supplemen-
tary Figure S10A). FANCJ depletion in the WT cells also
showed a significant 1.4-fold increase in the average num-
ber of RPA foci per cell. FANCJ-depleted RAP80 KO cells
showed 2.6-fold increase in RPA foci per cell compared to
the WT cells. For RAD51 staining, deficiency of FANCJ or
RAP80 in the MMC-treated cells resulted in 1.7-fold and 2-
fold increases in the average number of Rad51 foci per cell,
respectively, whereas depletion of both FANCJ and RAP80
resulted in a 3-fold increase in the number of RAD51 foci
per cell (Supplementary Figure S10B). Thus, in either the
RAP80 KO background or the FANCJ KO background
(Figure 3), loss of the additional player (FANCJ or RAP80,
respectively) exacerbated the level of MMC-induced RPA
and RAD51 staining, suggesting the elevated accumulation
of ssDNA and RAD51 protein filaments in MMC-treated
cells when both FANCJ and RAP80 are deficient.
Strand resection provoked by MMC-induced DNA damage is
dependent on CtIP and Mre11 nucleases
The accumulation of RPA and Rad51 foci in MMC-treated
cells co-deficient in FANCJ and RAP80 suggested to us
that the overly active DNA end-resection at sites of ICL-
induced DNA damage resulted in ssDNA accumulation. To
provide mechanistic insight, we sought to address if known
DNA end-resection nucleases are involved. First, we exam-
ined foci formation of CtIP, a known nucleolytic process-
ing enzyme that operates at DSBs in mammalian cells (42–
44). CtIP foci formation were visualized after a 1 h expo-
sure to 3 M MMC followed by recovery for 16 hr (Supple-
mentary Figure S11A). Under these conditions, 35% of WT
cells and 42% of FANCJ KO cells displayed greater than 10
CtIP foci per cell. WT cells depleted of RAP80 displayed a
significant 34% increase in CtIP immuno-staining, whereas
FANCJ KO cells depleted of RAP80 showed a 41% increase
compared to WT cells.
We next sought to address if CtIP was responsible for
ssDNA production in the MMC-treated cells, given our
observations that CtIP foci were significantly enriched in
the MMC-treated cells. CtIP depletion in FANCJ KO cells,
RAP80-depleted WT cells and FANCJ/RAP80 double-
deficient cells showed 22%, 28% and 30% of cells with >10
BrdU, respectively (Supplementary Figure S11B). The sig-
nificant reduction in BrdU foci for all these cell lines indi-
cates that CtIP is important for strand resection of MMC-
induced DNA damage in these genetic backgrounds.
We next asked if these same cells pretreated with 50 M
Mirin, a compound that inhibits the DNA end-processing
nuclease Mre11 (45), and then exposed to MMC under the
same conditions as described above, would display altered
BrdU foci abundance (Supplementary Figure S11B). Strik-
ingly, we observed only 7% of the Mirin-treated cells de-
pleted of both FANCJ and RAP80 to have >10 BrdU foci.
Mirin also suppressed BrdU foci in WT cells, as well as
those cells depleted of FANCJ or RAP80. These results sug-
gest that the ssDNA formed in the FANCJ/RAP80 double-
deficient cells is dependent on both the CtIP and Mre11 nu-
cleases.
Co-deficiency of FANCJ and RAP80 impairs double-strand
break repair
HR-mediated DSB repair is an important downstream
event in ICL repair; therefore, we sought to address the po-
tential interactive roles of FANCJ and RAP80 in DSB re-
pair. To assess the effect of deficiency in FANCJ, RAP80 or
both in DSB repair, we performed I-SceI-induced DSB re-
pair assays with cells depleted of FANCJ and/or RAP80
using a chromosomal integrated GFP reporter construct
to evaluate efficiency of HR repair or NHEJ (46). HR re-
pair of the I-SceI DSB was reduced 2.5-fold in FANCJ-
depleted cells and increased 1.4-fold in RAP80 cells (Fig-
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Figure 4. Cells depleted of FANCJ and RAP80 display reduced double-strand break repair by homologous recombination or nonhomologous end-joining.
The I-SceI DSB repair assay was used to measure HR repair or NHEJ of the indicated RNAi-depleted cell lines as described in Materials and Methods.
Panel (A), HR efficiency in siRNA transfected DR-GFP cells. Panel (B), NHEJ efficiency in siRNA transfected EJ5 cells. The results are mean ± standard
error of mean (s.e.m.) from three biological repeats, with P-values determined by Student’s t-tests.
and RAP80 (40,41). Interestingly, co-depletion of FANCJ
and RAP80 suppressed the elevated HR repair observed in
singly depleted RAP80 cells, bringing it to a level approx-
imating that observed in the FANCJ-depleted cells. Thus,
the elevated HR repair of I-SceI-induced DSBs observed in
RAP80-depleted cells was suppressed by a co-deficiency of
FANCJ.
Next, we measured NHEJ using the I-SceI DSB repair
assay (Figure 4B). Depletion of FANCJ or RAP80 alone
reduced NHEJ by nearly 2.5-fold, consistent with findings
from previous studies of FANCJ (47,48) and RAP80 (40).
Co-depletion of both FANCJ and RAP80 resulted in a sim-
ilarly reduced NHEJ, suggesting that they may behave in
an epistatic manner. Collectively, these results demonstrate
that co-depletion of FANCJ and RAP80 resulted in a sig-
nificant reduction in both HR and NHEJ, the two major
DSB repair pathways in the cell.
MMC-induced BRCA1 foci formation is compromised by the
Co-deficiency of FANCJ and RAP80
Given that BRCA1 plays a critical role in the response
to ICL-induced DNA damage and that both FANCJ and
RAP80 interact with BRCA1 in distinct sub-complexes
(49), we examined BRCA1 foci formation in FANCJ-
and/or RAP80-deficient cells after a 1 h exposure to 3 M
MMC and recovery for 16 h (Figure 5A-B). Upon exposure
to MMC the average number of BRCA1 foci per cell was
23 in the WT cells. FANCJ depletion reduced the average
number of BRCA1 foci per cell to 17. RAP80 depletion in
the WT cells exerted a greater effect by reducing the average
number of BRCA1 foci per cell to 11. Combined deficiency
of FANCJ and RAP80 led to the greatest reduction in the
average number of BRCA1 foci per cell to 6, indicating an
additive effect on ICL damage induced BRCA1 localization
caused by the loss of the two proteins. These results suggest
that FANCJ and RAP80 act upstream and at least partly
independently to elicit BRCA1 foci formation during the
ICL-induced DNA damage response.
BRCA1 recruitment to laser-induced psoralen-interstrand
cross-links is significantly reduced by a Co-deficiency of
FANCJ and RAP80
The functional involvement of FANCJ and RAP80 in the
DNA damage response and regulation of recombinational
repair led us to interrogate their importance in modulating
BRCA1 recruitment to laser-induced Pso-ICLs. Using the
isogenic FANCJ KO and WT cells transfected with RAP80-
RNAi or control siRNA, endogenous BRCA1 recruitment
to the Pso-ICL was detected in  -H2AX marked stripes
and quantified as sum intensity strip over background. As
shown in Figure 5D and E, the FANCJ KO or RAP80-
depleted WT cells both showed a significant diminishment
of BRCA1 recruitment intensity, suggesting they have roles
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Figure 5. FANCJ and RAP80 act upstream and independently to elicit BRCA1 foci during the cellular response to mitomycin C and recruitment of
BRCA1 to laser-induced psoralen cross-links. Panel (A), WT or FANCJ KO cells were transfected with 30 nM control siRNA or RAP80 siRNA#1.
After 24 h, cells were re-transfected with 30 nM control siRNA or RAP80 siRNA#1. Forty-eight hr after the first transfection, cells were treated with 3
M MMC for 1 h and allowed to recover in fresh media. Sixteen hours later, BRCA1 foci were examined after removing the soluble proteins and fixing
chromatin bound proteins. Representative images for BRCA1 foci in the indicated cell lines are shown. Panel (B), Quantitative analysis of MMC-induced
BRCA1 foci per cell. Over 100 cells were examined, and the results are mean ± standard error of mean (s.e.m.) from three biological repeats, with P-values
determined by Student’s t-tests. Panel (C), Western blot showing RNAi-mediated RAP80 depletion in the isogenic FANCJ KO or WT cell lines. Cells were
incubated with psoralen followed by laser treatment (1%) to induce Pso-ICLs. Cells were fixed and stained with anti-−H2AX and anti-BRCA1 antibody
Panel (D), representative images of −H2AX and BRCA1 stripes. Panel (E), Mean intensity of BRCA1 localized to ICL stripes were quantified in single
cells at 20 min after laser treatment. The results are mean ± standard error of mean (s.e.m.) from three biological repeats, with P-values determined by
Student’s t-tests.
sponse. Combined deficiency of FANCJ and RAP80 re-
sulted in the greatest reduction of BRCA1 recruitment to
the Pso-ICL, indicating that their effects on BRCA1 local-
ization to the ICL-induced DNA damage are at least in part
separate from one another.
DNA damage induced checkpoint severely compromised in
cells deficient in both RAP80 and FANCJ
Persistent DNA damage leads to checkpoint activation to
delay cell cycle progression and promote repair of the dam-
aged DNA (50). Activated cell cycle checkpoints prevent
cells from entering mitosis with the damaged DNA and
avoid mitotic catastrophe. BRCA1 recruitment is crucial
for the activation of the S- and G2/M-checkpoint (51,52).
BRCA1 forms at least 3 distinct complexes (BRCA1-A,
BRCA1-B and BRCA1-C). BRCA1-A complex is com-
prised of RAP80, Abraxas, BRCC36, BRCC45, BARD1,
BRCA1 and MERIT40. BRCA1-B complex is composed of
BRCA1, TopBP1 and FANCJ. BRCA1-C contains BRCA1,
CtIP, and MRN complex (39,49). Based upon these find-
ings and our own observations that FANCJ and RAP80
play distinct roles in ICL-induced BRCA1 foci formation
and BRCA1 recruitment to ICL-induced DNA damage, we
hypothesized that RAP80 (as a member of BRCA1-A) and
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pathways to activate cell cycle checkpoints elicited by MMC
exposure as marked by increase in phosphorylation of Chk1
at S317 and S345 (53,54).
As shown in Supplementary Figure S12, Chk1-S317 and
Chk1-S345 became phosphorylated in WT cells exposed to
3 M MMC. Depletion of RAP80 in the WT cells resulted
in a partial decrease in phosphorylation of Chk1-S317 or
Chk1-S345, as normalized to total Chk1. These results are
consistent with a previous report that Chk1 activation is de-
fective in RAP80-depleted cells exposed to ionizing radia-
tion (37). FANCJ KO cells displayed a more modest reduc-
tion in MMC-induced Chk1-S317 or Chk1-S345 phospho-
rylation, consistent with previous work suggesting a moder-
ate decrease in camptothecin-induced Chk1 activation (55).
However, combined deficiency of both FANCJ and RAP80
practically eliminated Chk1-S317 and Chk1-S345 phospho-
rylation, indicating a severely compromised ICL-induced
DNA damage checkpoint.
In response to IR-induced DNA damage, ATM phos-
phorylates Chk2 at residue T68 (56). A previous study
showed that camptothecin-treated FANCJ mutant cells dis-
play similar p-Chk2-T68 levels as FANCJ-WT cells (55). In
another study, it was reported that depletion of Abraxas (a
component of the BRCA1 complex A) also did not cause re-
duction of p-Chk2-T68 in IR-treated cells (24). In the cur-
rent study focused on ICL-induced DNA damage, we ob-
served that Chk2-T68 phosphorylation was induced in the
WT cells exposed to 3 M MMC. In comparison to WT
cells, loss of FANCJ, depletion of RAP80, or a deficiency
in both FANCJ and RAP80 showed similar levels of phos-
phorylated Chk2-T68 (Supplementary Figure S12). These
results suggest that unlike the ATR signaling pathway, the
loss of FANCJ and/or RAP80 did not significantly alter
the ATM-dependent checkpoint response compared to WT
cells exposed to the ICL-inducing agent MMC.
Although individual loss of FANCJ (57) or RAP80 (37)
has been reported to cause a defect in G2/M checkpoint ac-
tivation in response to IR-induced DNA damage, analysis
of the effect of combined loss of both FANCJ and RAP80 in
the G2/M checkpoint response has not been previously re-
ported. To understand the dual importance of FANCJ and
RAP80 in the MMC-induced checkpoint response, RAP80
was depleted in FANCJ KO cells and cells were stained
with phospho-H3 Ser10 which is a marker of condensed
chromosomes in mitotic cells (58). In the absence of exoge-
nously induced DNA damage, loss of FANCJ or RAP80
alone resulted in a 2-fold increase in mitotic index whereas
loss of both FANCJ and RAP80 together resulted in a 6-
fold increase (Supplementary Figure S13). Combined de-
ficiency of FANCJ and RAP80 in cells exposed to 3 M
MMC for 1 h followed by 18 h recovery resulted in an 18-
fold increase in mitotic index compared to only a 2-fold in-
crease for MMC-treated RAP80-depleted cells and a 7-fold
increase for MMC-treated FANCJ-depleted cells (Supple-
mentary Figure S13). These results suggest a synergistic ef-
fect of FANCJ and RAP80 loss on the G2/M checkpoint
response.
Abraxas/CCDC98 mediates the interaction of BRCA1
with other components of the BRCA1-A complex, which
include BRCC36, BRE, MERIT40 and RAP80 (35,59–61).
The Chen laboratory had shown that depletion of Abraxas
does not affect the formation of RAP80 foci, but reduces
the formation of BRCA1 foci after IR-induced DNA dam-
age (59). Thus, Abraxas functions downstream of RAP80,
serving as a bridge to recruit BRCA1. To confirm that the
phenotypes observed are dependent on BRCA1, we per-
formed MMC colony survival assays with Abraxas KO cells
depleted of FANCJ. At an MMC dose of 0.38 nM, FANCJ-
depleted Abraxas KO cells displayed 55% survival com-
pared to 92% survival for the Abraxas KO cells transfected
with control siRNA and 81% survival of WT cells depleted
of FANCJ (Supplementary Figure S14A). Therefore, the
combined deficiency of both FANCJ and Abraxas resulted
in a synergistic increase in MMC sensitivity. Similar results
were obtained with greater MMC doses (Supplementary
Figure S14A).
Phosphorylation of FANCJ at S990 is important for the
BRCA1-FANCJ interaction (57,62), which mediates the
DNA damage-induced G2/M checkpoint (57). RAP80 has
also been shown to be important for the G2/M check-
point as well as BRCA1 recruitment to IR-induced DSBs
(37,38,63). We hypothesized that FANCJ and RAP80 act in
parallel pathways to recruit BRCA1 to activate the G2/M
checkpoint; therefore, we wanted to ask if RAP80-depleted
cells expressing the FANCJ-S990A mutant protein would
show elevated sensitivity to MMC. At an MMC dose of
0.18 nM, the RAP80-depleted cells expressing FANCJ-
S990A were reduced by 20% compared to a 7% reduction
of RAP80-proficent cells expressing the FANCJ-S990A mu-
tant protein and 5% reduction for RAP80-depleted cells
(Supplementary Figure S14B). It is plausible that a distinct
role of FANCJ in ICL resistance is elicited when BRCA1
is not efficiently recruited to ICL-induced DNA damage,
analogous to its involvement in a switch from HR repair to
translesion-dependent synthesis by polymerase  (62).
Elevated chromosomal instability in cells doubly deficient for
FANCJ and RAP80
The increased level of DNA damage and defective check-
point response in cells that were deficient in both FANCJ
and RAP80 prompted us to assess if chromosomal instabil-
ity would be elevated due to cells progressing into mitosis
with DNA aberrations. Microscopic analysis of metaphase
spreads demonstrated a 5.5-fold greater number of chro-
mosomal abnormalities per metaphase in FANCJ KO cells
depleted of RAP80 compared to WT cells transfected with
control siRNA (Figure 6). FANCJ KO cells transfected with
control siRNA or WT cells depleted of RAP80 by RNAi
each displayed a 1.8-fold increase in chromosome aberra-
tions per metaphase, indicating that the co-deficiency of
both FANCJ and RAP80 has a significantly greater effect
on chromosomal instability than the additive loss of either
protein alone.
To determine whether structural chromosomal aberra-
tions accumulate due to a combined deficiency of FANCJ
and RAP80, metaphase spreads were analyzed cytogeneti-
cally for chromosomal alterations. Table 2 lists the types and
number of chromosomal abnormalities from metaphase
spreads. In addition to fragmentations, there were elevated
breaks, dicentrics, and fusions in cells doubly deficient for
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Figure 6. Elevated spontaneous chromosomal instability in cells deficient of FANCJ and RAP80. WT or FANCJ KO cells were treated with 30 nM
control or RAP80 siRNA#1. After 24 h cells were re-transfected with 30 nM control or RAP80 siRNA#1. Forty-eight hr after the first transfection, cells
were treated with 200 ng/ml of Colcemid for 3 hr and swollen in 75 mM KCl for 25 min at 37◦C. Cells were fixed on ice with a 3:1 methanol/acetic acid
solution. Metaphases were dropped onto slides preheated at 42◦C, allowed to dry, and stained with Giemsa. The numbers of chromosomal abnormalities
per metaphase were counted. Panel (A), Representative images of metaphase spreads. Panel (B), Quantification of chromosome abnormalities are mean ±
standard error of mean (s.e.m.) from three independent experiments, with P-values determined by Student’s t-tests.
number of radial chromosomes compared to additive de-
ficiency. Overall, these results demonstrate an increased
number of spontaneous chromosomal aberrations in the
FANCJ- and RAP80-depleted cells compared to their com-
bined single deficiencies.
FANCJ promotes three-stranded branch-migration in the 5′
to 3′ direction
The results from our experiments with cells deficient in
both FANCJ and RAP80 suggest that ICL-induced DNA
damage is improperly processed, resulting in overly resected
DNA ends that are not efficiently repaired by HR. This may
reflect the accumulation of strand invasion intermediates
that represent incompletely matured recombinant DNA
molecules due to lack of FANCJ helicase, an enzyme that is
implicated in HR repair but its role(s) is poorly understood.
Previously, it was reported that FANCJ can unwind forked
duplex and three-stranded non-mobile D-loop substrates
(13) and displace RAD51 bound to single-stranded DNA
(17) in an ATP-dependent manner; however, the ability of
FANCJ to branch-migrate three-stranded DNA structures
that represent early intermediates of HR repair had not
been assessed. Using purified recombinant FANCJ protein
and mobile three-way junction DNA substrates, we assayed
FANCJ’s ability to branch-migrate the DNA structures in a
5′ to 3′ or 3′ to 5′ direction. These substrates were previously
used to characterize the 3′ to 5′ branch-migration direction-
ality by the human RECQ1 DNA helicase (64) and the 5′ to
3′ directionality of the human Twinkle mitochondrial DNA
helicase (65). The results from these assays, shown in Figure
7A–C, demonstrate that FANCJ branch-migrates in the 5′
to 3′ direction with minimal detection of the expected prod-
uct from 3′ to 5′ branch-migration.
To determine if the observed branch-migration activity
by FANCJ was dependent on its intrinsic catalytic func-
tions, we compared the activity of FANCJ-WT with a site-
directed FANCJ mutant protein, the engineered Walker A
box FANCJ-K52R ATPase-dead variant (13). The FANCJ-
K52R mutant protein was significantly compromised in its
ability to perform branch-migration, suggesting that ATP
hydrolysis and strand separation activity typically ascribed
to ATP-dependent DNA unwinding are required for effi-
cient branch-migration catalyzed by FANCJ (Figure 7D
and E).
To address the possibility that the DNA product gen-
erated from reaction mixtures containing FANCJ and the
mobile three-stranded DNA substrate shown in Figure
7A is attributed to FANCJ helicase activity and not its
branch-migration activity, we performed an additional ex-
periment. The pre-existing forked duplex component of the
3-stranded substrate was incubated with FANCJ, ATP and
the single-stranded oligonucleotide complementary to the
nucleotide sequence in the unlabeled strand annealed to the
radiolabeled strand in the original forked duplex (Figure
7F). In this scenario, the unlabeled strand product of the
forked duplex substrate unwound by FANCJ could poten-
tially anneal to the single-stranded oligonucleotide origi-
nally in the reaction mixture, resulting in the release of the
radiolabeled single-stranded oligonucleotide. As shown in
Figure 7G, no such product was detected. In a control re-
action mixture, the radiolabeled forked duplex DNA sub-
strate was denatured by heat in the presence of the third
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Table 2. Lists the types and number of chromosomal abnormalities from metaphase spreads









No. of fragmented chromosomes 18 35 32 145
No. of breaks 20 42 35 101
No. of dicentric 18 32 31 68
No. of fusions 46 130 136 250
No. of multiradial chromosomes 0 8 1 22
Total no. of anomalies per spread 2 4.9 4.7 11.7
Figure 7. FANCJ promotes three-stranded DNA branch-migration in the 5′ to 3′ direction. DNA products of branch-migration reaction mixtures con-
taining a radiolabeled three-stranded DNA substrate FANCJ, and ATP as indicated in Materials and Methods were incubated for the indicated times and
resolved by electrophoresis on non-denaturing 8% polyacrylamide gels and visualized by autoradiography. DNA substrates were designed to detect 5′ to 3′
branch-migration activity (Panel A) or 3′ to 5′ branch-migration activity (Panel B). Representative results from at least three independent experiments are
shown. Quantitation of DNA products for Panels (A) and (B) is shown in Panel (C). Standard deviations are indicated by error bars. Panel (D), FANCJ-
WT or FANCJ-K52R (ATPase-deficient mutant) was incubated with 5′ to 3′ branch-migratable substrate in presence of ATP for 30 min and products
resolved by gel electrophoresis. Panel (E), Quantitation of at least three experiments from Panel (D). Panel (F), Depiction of experiments to distinguish
whether helicase or branch-migration is responsible for the product observed in Panel (A). The ssDNA added to the branch-migratable substrate used in
Panel (A) anneals to the upstream template strand (both entirely red). However, for the helicase assay the 5′ sequence (grey) of the ssDNA oligonucleotide
was changed such that it can only anneal after the 2-stranded DNA substrate was unwound first. Panel (G), FANCJ-WT was incubated with the helicase
substrate in the presence of ATP and a third partially complementary ssDNA oligonucleotide as depicted in the helicase activity schematic shown in Panel
(F). Note duplex length of substrate on left is 63 bp; as a control for FANCJ catalytic activity, a 19 bp forked duplex substrate was tested for unwinding
by FANCJ on the right.
was detected. The inability of FANCJ to unwind the 63 base
pair duplex of the substrate is consistent with our previ-
ous observations that while FANCJ is capable of unwinding
shorter duplex DNA substrates (e.g. 19-bp (Figure 7G, (13))
or 25-bp (66), the helicase is poorly processive and ineffi-
cient at unwinding DNA duplexes of 50-bp or more unless
the single-stranded DNA binding protein RPA is present
in the reaction mixture (67). Altogether, these results sug-
gest that FANCJ branch-migration activity of the three-way
junction was responsible for the single-stranded product de-
tected in Figure 7A.
DISCUSSION
Understanding the comprehensive network of proteins and
their partners responding to genomic DNA damage occur-
ring endogenously or induced by genotoxic compounds, en-
vironmental pollutants, ionizing or ultraviolet light radia-
tion or cancer chemotherapeutic drugs deserves attention as
the consequences of inefficiently repaired DNA damage can
be disastrous for human health in the case of unintended
exposure to caustic agents or clinically beneficial in terms









edical School user on 04 N
ovem
ber 2020
Nucleic Acids Research, 2020, Vol. 48, No. 16 9175
cells from the body. In this study, we have focused on the ge-
netic interactions of the FANCJ helicase implicated in ICL
repair with other DNA damage response/DNA repair fac-
tors that modulate the sensitivity of human cells to the ICL-
inducing agent MMC. Given that ICLs are highly toxic and
are used prolifically in the clinic to target rapidly dividing
and metabolizing cancer cells, the results from such studies
should provide insight from both basic science and clinical
application perspectives.
Using an exquisitely low dose of MMC in which even
FANCJ KO cells are hardly sensitive by proliferation or
colony survival, we interrogated the library of DNA dam-
age response/DNA repair genes for MMC sensitization.
This led to identification of 10 gene targets broadly dis-
tributed into four functional categories: (i) DNA damage
sensing, signaling and transducer factors (RAP80) (68),
ATM (69), OBFC2A(SSB2) (70), RAD23A (71)); (ii) TLS
(Polk, PolH, PCNA) (72); (iii) HR intermediate resolu-
tion (GEN1) (73); (iv) DNA repair (TDP1) (74) and re-
active oxygen species damage regulation (SOD1) (75). The
broad spectrum of pathway functions suggests the accumu-
lated DNA damage requires attention by cellular nucleic
acid processing machinery to avoid genotoxicity. Models for
replication-coupled ICL repair depict the collaborative ac-
tion of proteins involved in NER, TLS with the FA path-
way (8). We suspect that RAP80 (which regulates DNA
end-resection) helps FANCJ-deficient cells elicit alternative
forms of damage repair and activate cell cycle checkpoints.
Identification of RAP80 as a gene target was reinforced by
our observation that depletion of BRCC3/BRCC36 (an-
other member of the RAP80 complex (60)) in the MMC-
treated FANCJ KO cells caused their reduced proliferation
by 25% (Supplementary Figure S3).
With the connection of both FANCJ and RAP80 to
the tumor suppressor BRCA1 and their dual involvement
in the metabolism of DSBs, we focused the current work
on characterizing how the co-deficiency of FANCJ and
RAP80 leads to MMC hypersensitivity. As might be ex-
pected, FANCJ’s function was dependent on its catalytic
ATPase/helicase function suggesting that its ability to un-
wind duplex DNA and/or displace the major strand ex-
change protein RAD51 in an ATPase-dependent manner
are important. However, a key intermediate in HR repair (in
which FANCJ is believed to operate) is the three-stranded
displacement (D)-loop structure arising from single-strand
invasion into recipient homologous duplex mediated by
RAD51 in replicating (diploid) cells. A recent review from
the Heyer lab nicely describes the critical importance of
the strand invasion D-loop DNA intermediate as a deci-
sion mode for HR (76). Helicases and topoisomerases con-
trol the fate of such mobile three-stranded DNA struc-
tures in multiple ways including (i) removal of toxic joint
molecules; (ii) suppression of cross-overs; (iii) prevention
of multi-invasion induced rearrangements; (iv) assurance
of homology search accuracy. This led us to perform bio-
chemical assays to determine if FANCJ could catalyze
branch-migration of mobile three-way junction substrates.
FANCJ’s ability to perform branch-migration with a de-
fined directionality (5′ to 3′) distinguishes its activity from
that of the previously described RECQ1 DNA helicase
which operates in a 3′ to 5′ manner (64). It is plausible
that ATPase-dependent FANCJ branch-migration activity
characterized in the present study may play a role in the
repair of ICL-induced DNA damage or HR repair of a
DSB; however, this hypothesis requires further investiga-
tion. FANCJ’s ability to catalyze branch-migration in a 5′ to
3′ direction is distinguished from that of the DNA translo-
case RAD54 (77) or the BLM helicase (78), which were
shown to strongly branch-migrate with a 3′ to 5′ polarity
on longer DNA substrates (79). Consistent with a unique
role of FANCJ in HR, its deficiency resulted in reduced
HR repair of an I-SceI-induced chromosomal DSB ((18);
this study), a lesion that is predominantly repaired by a
homology-directed repair pathway (80).
Purified recombinant RTEL1, related to FANCJ by its se-
quence homology in the helicase core domain and Fe-S clus-
ter (81,82), was reported to disrupt a preformed plasmid-
based D-loop DNA substrate (83), and shown to displace
a third strand (characterized by a 3′ strand invasion) of a
non-mobile D-loop substrate in an RPA-dependent man-
ner (84); however its activity on branch-migrating three-
stranded DNA substrates was not assessed. Moreover, re-
cent work from the Sekelsky lab demonstrated that RTEL1
depletion or BLM depletion increased SDSA in human cells
(85), suggesting that either RTEL1 or BLM act to suppress
SDSA and that another DNA branch-migrating enzyme is
responsible for promoting SDSA. HR via the SDSA path-
way allows for non-crossover recombination, the most con-
servative outcome of HR that avoids structural alterations
or extensive genetic changes in daughter cells (76). Consis-
tent with a role of FANCJ to suppress cross-overs, we pre-
viously determined that FA-J fibroblasts displayed a signifi-
cantly greater level of sister chromatid exchange (SCE) than
wild-type cells (21).
Despite the experimental evidence that FANCJ facilitates
DSB repair by facilitating HR, the mechanistic details are
lacking. In this study, we present biochemical data show-
ing FANCJ branch-migrates mobile three-stranded DNA
structures (that represent a model strand invasion interme-
diate of HR) in an ATP-dependent manner in vitro. Given
FANCJ’s importance in the ICL response, we postulate that
FANCJ enables the timely maturation of the HR interme-
diate in a manner dependent on its catalytic function. In the
future, separation-of-function mutants that specifically in-
activate the branch-migration activity of FANCJ (but leave
intact helicase activity) would be useful to explore the rele-
vance of FANCJ’s specific catalytic activities in human cells.
The relationship of BRCA1 to FANCJ or RAP80 in the ICL
DNA damage response is complex, given that BRCA1 can
independently form sub-complexes with either protein, as
well as CtIP. Our findings demonstrate that ssDNA which
accumulates in MMC-treated cells co-deficient in FANCJ
and MRE11 is dependent on MRE11/CtIP nuclease pro-
cessing of the DNA damage.
Our HR reporter results are consistent with a model in
which an increase in HR upon RAP80 depletion is likely
attributed to an increase in DNA end-resection at DSBs
and creation of single-stranded DNA overhangs (40,41).
Loss of both FANCJ and RAP80 resulted in a significant
reduction in HR to nearly the level of FANCJ-depleted
cells despite our observations that RPA and Rad51 foci in
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that RAP80 deficiency results in an increased resection and
single-stranded DNA generation; however, the concomitant
loss of FANCJ in these cells compromises repair of the HR
intermediates.
RAP80 behaves like by 53BP1 by acting as a barrier to the
end-resection process (86). Indeed, while RAP80 deficiency
was reported to reduce IR-induced BRCA1 foci, it ironi-
cally increases long-strand resection (41,86). Similarly, loss
of 53BP1 has been shown to promote DNA end-resection
in the absence of BRCA1, resulting in Rad51 foci formation
in cells exposed to IR or MMC (87–90). Our studies suggest
that under conditions of a RAP80 deficiency, CtIP may act
either in complex with residual BRCA1 or independently
of BRCA1 at sites of ICL-induced DNA damage to aid in
strand resection.
The HR phenotypes (scored by the restriction digest
chromosomal recombination assay) due to either a FANCJ
deficiency (resulting in decreased HR) or RAP80 deficiency
(resulting in elevated HR) is consistent with what was re-
ported by others. The combined FANCJ and RAP80 defi-
ciency suppresses the elevated HR seen with RAP80 defi-
ciency. However, it must be stressed that a restriction en-
zyme induced DSB is distinct from ICL-induced DNA
damage, the latter not only leading to DSBs but also in-
terfering with transcription and replication. Moreover, the
processing steps involved in ICL repair are considerably
more involved than repair of DSBs via either HR or NHEJ.
Therefore, while findings at a frank DSB for FANCJ or
RAP80 (as well as other DNA damage response proteins)
are informative, at ICL-induced lesions the range of func-
tions could be expanded or distinct. This would apply to the
resection step and its relationship to the processing of spe-
cific forms of DNA damage, as well as more broadly the
DNA damage response overall when forks are prevented
from proceeding normally. The focus of the current study
was the cellular response to ICL-induced DNA damage im-
posed by MMC, as defined by our original RNAi screen
which led to the identification of RAP80 as a genetic in-
teracting factor with FANCJ. Stalled and reversed forks,
as well as processed forks and DSBs, are all DNA struc-
tures that arise in vivo due to ICL-induced damage. The el-
evated RPA and RAD51 foci in cells that are co-deficient
in FANCJ and RAP80 after MMC exposure and recovery
under the conditions of the RNAi screen are likely to re-
flect aberrant hyper-recombination and ineffective process-
ing of HR intermediates in addition to improperly metabo-
lized stalled or regressed replication forks. The new experi-
mental data showing kinetics of RPA and RAD51 foci for-
mation in response to MMC exposure support the findings
that these DNA damage proteins are altered in their subcel-
lular localization as a function of FANCJ/RAP80 status.
Previous studies demonstrated that BRCA1 forms sepa-
rate and distinct complexes with RAP80, FANCJ and CtIP
(91). Loss of the RAP80–BRCA1 interaction in RAP80-
deficient cells was reported to increase the BRCA1-CtIP in-
teraction which can enhance end-resection leading to ele-
vated RAD51 and RPA foci in IR-treated cells (41). This
is consistent with our observations that there is increased
CtIP foci formation in MMC-treated RAP80-depleted cells
(Supplementary Figure S11A), and that CtIP depletion re-
sulted in a significant reduction of BrdU foci (Supplemen-
tary Figure S11B). Altogether, the results suggest that CtIP
(and Mre11) is responsible for the end-resection in MMC-
treated cells that are deficient in RAP80.
The roles of CtIP in the DNA damage response appear to
be complex. CtIP deficiency negatively affects the response
of DNA damage response proteins to laser induced ICLs
(92). In contrast, the same study found that H2AX and
phosphorylated ATM recruitment to laser generated DSBs
are unaffected by CtIP status. Recently, Nath et al. reported
that a FANCJ deficiency caused a reduction in CtIP re-
cruitment to AsiSI-induced DSBs (93). FANCJ S900 phos-
phorylation and K1249 acetylation were found to be im-
portant for interaction with CtIP and DSB end-resection
at AsiSI-induced DSBs. In our work, we determined that
CtIP foci formation in FANCJ-deficient cells after MMC
exposure and recovery was not significantly different from
WT cells. CtIP’s involvement in genomic stability appears
to be multi-faceted, depending in part on the type of DNA
damage. Experimental evidence suggests that monoubiq-
uitinated FANCD2 aids CtIP in channeling DSBs arising
from ICL processing into the HR pathway; conversely, CtIP
suppresses illegitimate recombination in FA-deficient cells
(94). Understanding FANCJ’s crosstalk with CtIP in the
DNA damage response will require further study.
Cells co-deficient in FANCJ and RAP80 acutely ex-
posed to MMC and allowed to recover displayed signifi-
cantly elevated RPA and Rad51 foci compared to a sin-
gle deficiency in either FANCJ or RAP80. The increased
RPA and RAD51 staining suggest that FANCJ and RAP80
play at least partly independent functions in HR repair
of MMC-induced DNA damage. Earlier it was reported
that Fancj−/− mouse embryonic fibroblasts exposed to
MMC displayed elevated RAD51 positive staining dur-
ing the recovery period (95), consistent with the findings
in this study. FANCJ may help to mature HR intermedi-
ates and suppress the persistence of RAD51 protein fil-
aments via its dual roles in DNA branch-migration (this
study) and ability to displace Rad51 bound to DNA and
modulate Rad51 strand exchange (17). The accumulation
of ssDNA tracts at laser-activated Pso-ICLs in cells co-
deficient of FANCJ and RAP80 suggests a model in which
ICL-induced DNA damage leads to DSBs which over
time become overly resected and not matured by the HR
pathway. A previous study demonstrated that depletion
of the DNA2 helicase/nuclease suppressed cisplatin sensi-
tivity of FANCD2-deficient cells, suggesting that DNA2-
mediated over-resection is responsible for aberrant DNA
repair (96). Our study implicates FANCJ as a key player
to suppress ICL-induced DNA damage by helping to pro-
cess single-stranded DNA via maturation of HR intermedi-
ates, thereby ensuring chromosomal stability. Interestingly,
the BLM helicase (which interacts with FANCJ (21)) is
proposed to suppress excessive HR by its recruitment to
hydroxyurea-induced stalled replication forks; RAP80’s in-
teraction with ubiquitylated BLM is required for its recruit-
ment (97).
Experimental data from several labs demonstrated that
RAP80 helps recruit BRCA1 to sites of DSBs where
BRCA1 modulates cell cycle checkpoint and DNA dam-
age response (37–39). Our results showing that deficiency
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BRCA1 foci suggest that both FANCJ and RAP80, in
their distinct complexes with BRCA1, aid in its recruit-
ment to ICL DNA damage and DSBs. The dysregulation
of BRCA1 localization to sites of DNA damage due to co-
deficiency of FANCJ and RAP80 is likely to contribute to
the aberrant cell cycle checkpoint function. This hypothe-
sis led us to directly test if BRCA1’s recruitment to ICL-
induced DNA damage is compromised by loss of RAP80
and/or FANCJ by examining BRCA1 nuclear localization
to the site of a laser-induced Pso-ICL. The significant re-
duction in BRCA1 staining intensity at the site of irradiated
damage confirmed that both FANCJ and RAP80 are im-
portant for BRCA1 recruitment to the ICL damage. Alto-
gether, our results suggest that the defective localization of
BRCA1 to sites of ICL damage contributes to the reduced
DNA repair and chromosomal instability characteristic of
RAP80- and FANCJ-deficiency. Consistent with a coordi-
nate of BRCA1 and FANCJ to help cells deal with DNA
damage, the complex formation of FANCJ with BRCA1
is required for HR repair (98) and repression of mutagenic
end-joining of DSBs (47). It is likely that FANCJ-defective
cells elicit the activity of other helicases to deal with either
frank DSBs or those incurred by ICLs. Likewise, the ap-
parently dual roles of FANCJ in DSB repair by HR and
NHEJ suggest that compensatory pathways are evoked to
help cells cope with endogenous or exogenously induced
DSBs; however, this significant line of investigation is be-
yond the scope of the present study. FANCJ’ s newly discov-
ered biochemical activity to branch-migrate mobile DNA
junctions in an ATP-dependent manner is likely to be im-
portant for modulating HR repair of ICL-induced DNA
damage, a pathway observed to be dependent on a thresh-
old of FANCJ catalytic activity (36).
Beyond their direct involvement in DNA repair, both
FANCJ and RAP80 play roles in checkpoint activation.
However, it has not been determined if the two proteins act
in the same pathway or not. Our results clearly demonstrate
the DNA damage induced checkpoint elicited by MMC ex-
posure is severely compromised in cells deficient in both
FANCJ and RAP80 compared to the single loss of either.
Thus, the co-deficiency of FANCJ and RAP80 represents
a double-edged sword as both repair of ICL-induced DNA
damage and the checkpoint response are crippled, allowing
cells with toxic DNA damage to proceed into mitosis. The
resulting chromosomal instability and mitotic catastrophe
leading to cell loss suggests that both DNA repair modula-
tion and checkpoint activation by FANCJ and RAP80 are
crucial for survival when cells are challenged with even a
relatively low level of a DNA cross-linking agent.
The synergism of RAP80 (and other DNA damage re-
sponse factors (e.g. Merit40)) with FANCJ raises the pos-
sibility their genetic interaction may be informative from a
clinical perspective. Yan et al. found that RAP80 depletion
by RNAi increased radio-sensitivity of the breast cancer
cell line MCF-7 (99). Screening of BRCA1/BRCA2 muta-
tion negative breast cancer cases revealed numerous genetic
alterations in RAP80, including a single amino acid dele-
tion mutation in a ubiquitin interaction motif that impaired
DSB localization and recruitment of other DNA repair
proteins, and was associated with chromosomal instability
(100). Similarly, a screen of FANCJ mutation-associated
cancers may be informative to assess RAP80 mutational
status, given our observations that chromosomal instabil-
ity is significantly elevated in cells deficient in both FANCJ
and RAP80.
A recent study reported that RAP80 expression in inva-
sive ductal breast cancer tissues is significantly lower than
in paired normal breast tissues (101). It is plausible that
the efficacy of DNA damaging chemotherapy drugs or ra-
diation and the outcome of breast or ovarian cancer pa-
tients with deficiency in FANCJ or related tumor suppres-
sors is dependent on the expression level of RAP80 and
other factors that modulate DNA repair or the DNA dam-
age response. Supporting this idea, depletion of RAP80
by RNA interference induced apoptosis, down-regulated
invasiveness/migration, and enhanced cisplatin sensitivity
of breast cancer cells (101).
Devising improved chemotherapeutic drug or radiation
strategies will require a better understanding of the over-
lapping versus unique pathways that tumor suppressor pro-
teins like FANCJ and RAP80 operate with other factors to
stabilize the genome. Achieving a therapeutic threshold may
be enhanced by a comprehensive assessment of gene inter-
actions relevant to the DNA damage response.
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